Maciej Kinalski

678 total citations
26 papers, 557 citations indexed

About

Maciej Kinalski is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Maciej Kinalski has authored 26 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Obstetrics and Gynecology, 8 papers in Reproductive Medicine and 7 papers in Molecular Biology. Recurrent topics in Maciej Kinalski's work include Endometrial and Cervical Cancer Treatments (6 papers), Diabetes and associated disorders (6 papers) and Ovarian cancer diagnosis and treatment (5 papers). Maciej Kinalski is often cited by papers focused on Endometrial and Cervical Cancer Treatments (6 papers), Diabetes and associated disorders (6 papers) and Ovarian cancer diagnosis and treatment (5 papers). Maciej Kinalski collaborates with scholars based in Poland, United States and Italy. Maciej Kinalski's co-authors include S Terlikowski, Bożena Dobrzycka, Katarzyna M. Terlikowska, Beata Maćkowiak-Matejczyk, I Kinalska, Adam Krętowski, Z Puchałski, Anna Karpińska, Oksana Kowalczuk and Anna Kuryliszyn-Moskal and has published in prestigious journals such as Diabetes, Gynecologic Oncology and BMC Cancer.

In The Last Decade

Maciej Kinalski

25 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maciej Kinalski Poland 13 177 146 144 124 97 26 557
Joachim Alfer Germany 14 315 1.8× 143 1.0× 223 1.5× 135 1.1× 124 1.3× 27 819
Nisreen Abu Shahin Jordan 12 138 0.8× 171 1.2× 88 0.6× 93 0.8× 67 0.7× 40 466
Paweł Mach Germany 16 127 0.7× 115 0.8× 210 1.5× 152 1.2× 53 0.5× 59 646
Marek Grabiec Poland 15 152 0.9× 235 1.6× 145 1.0× 250 2.0× 88 0.9× 71 707
Karim ElSahwi United States 12 134 0.8× 119 0.8× 80 0.6× 192 1.5× 116 1.2× 25 527
Małgorzata Walentowicz‐Sadlecka Poland 14 126 0.7× 128 0.9× 52 0.4× 130 1.0× 69 0.7× 40 488
Stinne Ravn Greisen Denmark 13 122 0.7× 90 0.6× 266 1.8× 53 0.4× 54 0.6× 36 622
Rosekeila Simões Nomelini Brazil 14 95 0.5× 250 1.7× 183 1.3× 164 1.3× 77 0.8× 67 653
Mitsunori Matsuo Japan 16 125 0.7× 303 2.1× 411 2.9× 222 1.8× 126 1.3× 54 819
Zbigniew Kojs Poland 12 74 0.4× 129 0.9× 43 0.3× 125 1.0× 66 0.7× 70 453

Countries citing papers authored by Maciej Kinalski

Since Specialization
Citations

This map shows the geographic impact of Maciej Kinalski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maciej Kinalski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maciej Kinalski more than expected).

Fields of papers citing papers by Maciej Kinalski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maciej Kinalski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maciej Kinalski. The network helps show where Maciej Kinalski may publish in the future.

Co-authorship network of co-authors of Maciej Kinalski

This figure shows the co-authorship network connecting the top 25 collaborators of Maciej Kinalski. A scholar is included among the top collaborators of Maciej Kinalski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maciej Kinalski. Maciej Kinalski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dobrzycka, Bożena, Katarzyna M. Terlikowska, Oksana Kowalczuk, et al.. (2024). Prognosis of Stage I Endometrial Cancer According to the FIGO 2023 Classification Taking into Account Molecular Changes. Cancers. 16(2). 390–390. 10 indexed citations
2.
Terlikowska, Katarzyna M., et al.. (2020). Clinical value of selected markers of angiogenesis, inflammation, insulin resistance and obesity in type 1 endometrial cancer. BMC Cancer. 20(1). 921–921. 22 indexed citations
3.
Terlikowska, Katarzyna M., Bożena Dobrzycka, Maciej Kinalski, & S Terlikowski. (2020). Serum Concentrations of Carotenoids and Fat-Soluble Vitamins in Relation to Nutritional Status of Patients with Ovarian Cancer. Nutrition and Cancer. 73(8). 1480–1488. 8 indexed citations
4.
Terlikowska, Katarzyna M., Bożena Dobrzycka, Anna Maria Witkowska, et al.. (2016). Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses. Journal of Ovarian Research. 9(1). 43–43. 36 indexed citations
5.
Dobrzycka, Bożena, Beata Maćkowiak-Matejczyk, Katarzyna M. Terlikowska, Maciej Kinalski, & S Terlikowski. (2015). Utility of HE4 to identify patients with endometrioid endometrial cancer who may require lymphadenectomy. Advances in Medical Sciences. 61(1). 23–27. 16 indexed citations
6.
Dobrzycka, Bożena, et al.. (2015). Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma. Tumor Biology. 36(6). 4157–4165. 31 indexed citations
7.
Wolańska, Małgorzata, et al.. (2014). Cathepsin B in human myometrium and in uterine leiomyomas at various stages of tumour growth. European Journal of Obstetrics & Gynecology and Reproductive Biology. 185. 140–144. 4 indexed citations
8.
Dobrzycka, Bożena, et al.. (2013). Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer. European Cytokine Network. 24(3). 106–113. 67 indexed citations
9.
Terlikowski, S, Bożena Dobrzycka, Maciej Kinalski, Anna Kuryliszyn-Moskal, & S Terlikowski. (2013). Transvaginal electrical stimulation with surface-EMG biofeedback in managing stress urinary incontinence in women of premenopausal age: a double-blind, placebo-controlled, randomized clinical trial. International Urogynecology Journal. 24(10). 1631–1638. 52 indexed citations
10.
Kinalski, Maciej, et al.. (2012). Frequently Missed Abdominal Compartment Syndrome. Polish Journal of Surgery. 84(8). 426–8.
11.
Dobrzycka, Bożena, Beata Maćkowiak-Matejczyk, Maciej Kinalski, & S Terlikowski. (2012). Pretreatment serum levels of bFGF and VEGF and its clinical significance in endometrial carcinoma. Gynecologic Oncology. 128(3). 454–460. 26 indexed citations
12.
Dobrzycka, Bożena, S Terlikowski, Wiesława Niklińska, et al.. (2010). Tumor necrosis factor-alpha and its receptors in epithelial ovarian cancer.. Folia Histochemica et Cytobiologica. 47(4). 609–13. 20 indexed citations
13.
Dobrzycka, Bożena, S Terlikowski, Oksana Kowalczuk, & Maciej Kinalski. (2009). Circulating levels of TNF-α and its soluble receptors in the plasma of patients with epithelial ovarian cancer. European Cytokine Network. 20(3). 131–134. 36 indexed citations
14.
Dobrzycka, Bożena, et al.. (2009). [The role of estrogens in angiogenesis in the female reproductive system].. PubMed. 60(3). 210–4. 8 indexed citations
15.
Kinalska, I, Anna Popławska‐Kita, Beata Telejko, Maciej Kinalski, & Anna Zonenberg. (2006). Otyłość a zaburzenia przemiany węglowodanowej. Via Medica Journals. 2(3). 94–101. 4 indexed citations
16.
Kinalski, Maciej, et al.. (2006). [Tumor necrosis factor-alpha system in patients with gestational diabetes].. PubMed. 63(4). 173–5. 5 indexed citations
17.
Kinalski, Maciej, et al.. (2006). [Pregnancy complicated by diabetes mellitus].. PubMed. 8(3 Pt 2). 691–701. 3 indexed citations
18.
Kinalski, Maciej, et al.. (2003). Wskaźniki ryzyka ujawnienia się cukrzycy ciężarnych. Clinical Diabetology. 4(4). 257–264. 1 indexed citations
19.
Krętowski, Adam, Janusz Myśliwiec, Małgorzata Szelachowska, Maciej Kinalski, & I Kinalska. (2000). Nicotinamide inhibits enhanced in vitro production of interleukin-12 and tumour necrosis factor-α in peripheral whole blood of people at high risk of developing Type 1 diabetes and people with newly diagnosed Type 1 diabetes. Diabetes Research and Clinical Practice. 47(2). 81–86. 13 indexed citations
20.
Myśliwiec, Janusz, Adam Krętowski, Maciej Kinalski, & I Kinalska. (1999). CD11a Expression and soluble ICAM-1 levels in peripheral blood in high-risk and overt type 1 diabetes subjects. Immunology Letters. 70(1). 69–72. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joachim Alfer Breakdown of academic impact, for papers by Nisreen Abu Shahin Breakdown of academic impact, for papers by Paweł Mach Breakdown of academic impact, for papers by Marek Grabiec Breakdown of academic impact, for papers by Karim ElSahwi Breakdown of academic impact, for papers by Małgorzata Walentowicz‐Sadlecka Breakdown of academic impact, for papers by Stinne Ravn Greisen Breakdown of academic impact, for papers by Rosekeila Simões Nomelini Breakdown of academic impact, for papers by Mitsunori Matsuo Breakdown of academic impact, for papers by Zbigniew Kojs
Rankless by CCL
2026